•
Don’t Monkey Around With Monkeypox
Talks about Medicine, Monkeypox and Monkeypox Virus
DE
David Epstein
Past Chief Executive Officer Seagen
Delray Beach, Florida
Overview
David Epstein is currently the Chief Executive Officer at Seagen, with a background in the pharmaceutical industry and expertise in oncology, biotechnology, and healthcare. His notable career highlights include serving as Chairman at Agomab and holding board positions at various companies such as Tempus AI and Cellestia Biotech.
Work Experience
Chairman
2024 - Current
Board Member
2024
Board Member
2020
Pelican Harbor Seabird Station is a Center for Seabird Rehabilitation.
Board Member
2019
Valo Health is a technology company focused on utilizing large scale data and AI-driven computation to discover and develop therapeutics.
Raised $460,000,000.00 from HBM Healthcare Investments.
Managing General Partner
2016
Consulting and Board Services
Chief Executive Officer
2022 - 2023
Company sold
Seagen is a clinical-stage biotechnology company dedicated to improving patient outcomes with advanced antibody-drug conjugate technology.
Raised $2,219,000,000.00 from Merck, Takeda and New Enterprise Associates.
Independent Director
2022 - 2023
Independent Director
2020 - 2023
Independent Director
2018 - 2023
Chairman until June 2022
Evelo Biosciences is a biotechnology company that develops oral biologics for small intestinal axis with systemic therapeutic effects.
Raised $397,000,003.00 from Horizon Technology Finance and K2 HealthVentures.
Independent Director
2021 - 2022
Ring Therapeutics is a gene therapy company focused on discovering and developing programmable genetic medicines.
Raised $253,500,000.00 from Altitude Life Science Ventures, Flagship Pioneering, UPMC Enterprises, CJ Investment, Partners Investment, T. Rowe Price, Alexandria Venture Investments, Invus and Kyowa Kirin.